RTTNews | Apr 12, 2021 07:55AM EDT

07:54 Monday, April 12, 2021 (RTTNews) - Jazz Pharma Announces FDA Acceptance And Priority Review Of SNDA For Xywav Oral Solution In Idiopathic Hypersomnia

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved